Study of Telaprevir in Subjects With Hepatic Impairment

Clinical trial NCT00509210 · COMPLETED

Trial details

NCT number: NCT00509210
Sponsor: Vertex Pharmaceuticals Incorporated
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Insufficiency

Start date: 2007-09-01
Primary completion: 2008-06-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.